PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

PHASE1CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Hypertension
Interventions
DRUG

YH22162

DRUG

Telmisartan/Amlodipine 80/5 mg (FDC)

DRUG

Chlorthalidone 25mg

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02496910 - PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton | Biotech Hunter | Biotech Hunter